One thing I'd like to clear up for people regarding the 200K vials per country. After speaking to the company, they have not limited 200K to each country. They committed the entire inventory subject to approval.
Food for thought as we are 1 step closer to being a MULTI-billion dollar company. All, IMO.
Remember, as more and more medical staff use this treatment, its growth will be exponential! As their understanding grows, so will our earnings. As more lives are saved approvals will come.
They can't get the Brazil trials done fast enough.
Not revenue producing. No revenue at all in that PR. Read it again. They EXPECT it to produce revenue. You must read these PR's carefully friend they are worded carefully so read them carefully.
News 
Market Data 
Discover 
AI
